<DOC>
	<DOCNO>NCT00989521</DOCNO>
	<brief_summary>PUR003 inhale substance propose assist treatment asthma . Study objectives : 1. evaluate safety PUR003 subject asthma , 2. evaluate efficacy PUR003 assist treatment asthma .</brief_summary>
	<brief_title>Effect PUR003 Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Bronchial Diseases</mesh_term>
	<criteria>1 . Signed write informed consent . 2 . Ability willingness return outpatient clinic repeat clinic visit complete assessment . 3 . Adult male female subject , 1860 year age . 4 . Stable , mild asthma require medical treatment short act inhaled bronchodilator , need . 5 . No smoking within six month prior entry 6 . Must medically stable . 7 . Female subject must negative pregnancy test 8 . Subjects child bear potential sexually inactive ( abstinent ) 14 day prior first dose study medication use acceptable form birth control method . 1 . History presence significant coexist chronic disease . 2 . History asthma exacerbation upper low respiratory illness ( viral respiratory syndrome , bronchitis , pneumonia ) within four week first visit . 3 . Pregnancy , breastfeed . 4 . Abused alcohol illicit drug require treatment . 5 . Participated investigational drug evaluation within last 30 day . 6 . Scheduled elective invasive medical intervention , procedure , surgery within 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>bronchial disease</keyword>
	<keyword>lung disease</keyword>
	<keyword>bronchitis</keyword>
	<keyword>respiratory tract disease</keyword>
</DOC>